Study of symptomatology in patients with chronic obstructive lung diseases at a tertiary care hospital

 

Gaurav R Dubey¹, Anjali S Deshmukh^2*, Vijay R Kapse³

 

¹Assistant Professor, Department of TB and Respiratory Medicine, Dr PDMMC Amravati, Maharashtra, INDIA.

²Assistant Professor, ³Associate Professor, Department of Medicine, Dr.S.C.G.M.C.Nanded, Maharashtra, INDIA.

Email: dr.dranju@rediffmail.com

 

REFERENCES

1. Agusti AG. Systemic effects of chronic obstructive pulmonary Disease. Proc Am Thorac Soc2005; 2:367-70.
2. Antó JM, Vermeire P, Vestbo J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J2001; 17:982-94.
3. Changing the burden of copd mortality. Int J Chron Obstruct Pulmon Dis2006; 1:219-33.
4. Motiani B, Haidri FR, Rizvi N. Frequency of depression in chronic obstructive pulmonary disease (COPD) patients. Pak J Med Sci2011; 27:1112-5.
5. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997 May; 349(9064):1498–504.
6. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest. 2000 Feb; 117(2 Suppl):5S–9S.
7. Murali Mohan BV, Sen T, Ranganath R. Systemic manifestations of COPD. J Assoc Physicians India 2012; 60 Suppl: 44-7.
8. Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, Mannino D, et al. COPD as a lung disease with systemic consequences‑‑clinical impact, mechanisms, and potential for early intervention. COPD 2008; 5:235-56.
9. Barnes PJ. Chronic obstructive pulmonary disease: Effects beyond the lungs. PLoS Med 2010; 7:e1000220.
10. Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182:693-718.
11. Lundbäck B, Lindberg A, Lindström M, et al. Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003; 97:115-22.
12. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009; 374:733-43.
13. Perret JL, Dharmage SC, Matheson MC, et al. The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age. Am J Respir Crit Care Med 2013; 187:42-8.
14. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD [updated 2009; accessed 15 April 2010]. Available from: www.goldcopd.com
15. Han MK, Postma D, Mannino DM, Giardino ND, Buist S, Curtis JL, Martinez FJ. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med 2007; 176:1179–1184.
16. Kirkpatrick P, Dransfield MT. Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment. Curr Opin Pulm Med 2009; 15:100–104.
17. Løkke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006; 61:935–939.
18. Johannessen A, Omenaas E, Bakke P, Gulsvik A. Incidence of GOLDdefined chronic obstructive pulmonary disease in a general adult population. Int J Tuberc Lung Dis 2005; 9:926–932.
19. Lindberg A, Eriksson B, Larsson LG, Ro ¨nmark E, Sandstro ¨m T, Lundba ¨ck B. Seven-year cumulative incidence of COPD in an agestratified general population sample. Chest 2006; 129:879–885.
20. Van Durme YM, Verhamme KM, Stijnen T, van Rooij FJ, Van Pottelberge GR, Hofman A, Joos GF, Stricker BH, Brusselle GG. Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam study. Chest 2009; 135:368– 377.
21. Wongsurakiat P, Lertakyamanee J, Maranetra KN, Jongriratanakul S, Sangkaew S. Economic evaluation of influenza vaccination in Thai chronicobstructive pulmonary disease patients. J Med AssocThai 2003; 86:497–508.
22. Sanchez SP, Divo M, Casanova C, Pinto-Plata V, de-Torres JP, Cote C, et al. Disease progression in young patients with COPD: retkinking the Fletcher and Peto model. Eur Respir J 2014; 44:324-31.
23. Al Ghobain M, Al Moamary MS, Al Shehri SN, Al Hajjaj MS. Prevalence and characteristics of cigarette smoking among 16 to 18 years old boys and girls in Saudi Arabia. Ann Thorac Med 2011; 6:137-40.
24. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364: 613–20.
25. Xu F, Yin X, Zhang M, et al. Prevalence of physiciandiagnosed COPD and its association with smoking among urban and rural residents in regional mainland China. Chest 2005; 128:2818–23.
26. Liu SM, Wang XP, Wang DL, et al. Epidemiologic analysis of COPD in Guangdong province. Chin Med J 2005; 85:747–52.
27. Ran PX, Wang C, Yao WZ, et al. The risk factors for chronic obstructive pulmonary disease in females in Chinese rural areas. Chin J Integr Med 2006; 45:974–9.
28. Lokke A, Lange P, Scharling H, et al. Developing COPD: a 25 year follow up study of the general population. Thorax 2006; 61:935–9.
29. Tverdal A, Bjartveit K. Health consequences of reduced daily cigarette consumption. Tob Control 2006; 15:472–80.
30. Jain NK, Thakkar MS, Jain N, Rohan KA, Sharma M. Chronic obstructive pulmonary disease. Does gender really matter? Lung India. 2011; 28(4):25862.
31. Kamdar DJ, Patel DK. A study of the clinical profile of 50 patients of COPD with correlation between clinical, radiological and spirometric evaluation. Int J Res Med Sci 2017; 5:1802-7.